Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: J Thorac Oncol. 2012 Sep;7(9):1440–1448. doi: 10.1097/JTO.0b013e318260deaa

Table 4.

Associations between protein expression of FPGS (4A) or TS (4B) and objective response (OR) or disease control (DC). Responding and non-responding patients were compared and significant differences in the mean or median FPGS H-Score for OR or DC as well as in the mean or median TS H-Score for DC were found.

Table 4A
Number of patients Mean pretreatment FPGS H-score ± SEM, median P-value
OR 0.0030
PR 36 248 ± 6, 255
SD + PD 45 221 ± 6, 220
DC 0.0208
PR + SD 72 236 ± 5, 240
PD 9 209 ± 8, 200
Table 4B
Number of patients Mean pretreatment TS H-Score ± SEM, median P-value
OR 0.6752
PR 34 211 ± 8, 210
SD + PD 42 213 ± 8, 220
DC 0.0383
PR + SD 67 208 ± 6, 210
PD 9 246 ± 12, 260